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AdhesionsAbstract Background: Pleural malignancy either primary or due to metastatic involvement can be
presented by different macroscopic appearances in thoracoscopic examination of pleural cavity.
Purpose: To identify the relationship between thoracoscopic view of different malignant pleural
lesions and pathological types of malignancy in malignant pleural effusion.
Patients and methods: A retrospective study reviewing medical reports of sixty-nine (69) patients
who underwent medical thoracoscopy and were conﬁrmed to be malignant pleural effusion by pleu-
ral tissue biopsy as well as macroscopic appearances of malignant pleural lesions were identiﬁed.
Results: Metastatic adenocarcinoma was the main type of malignancy (46 cases 66.7%), fol-
lowed by malignant lymphoma (9 cases 13%), malignant mesothelioma (4 cases 5.8%), squamous
cell carcinoma (4 cases 5.8%), small cell carcinoma (3 cases 4.3%), sarcoma (2 cases 2.9%) and
lastly spindle cell tumor (single case 1.4%). Nodular appearance of malignant pleural lesions was
the main thoracoscopic ﬁnding (75.45%) followed by masses (50.7%), plaques (20.3%) and lastly
adhesions (14.5%) of cases. Nodules represented the main thoracoscopic ﬁnding in both metastatic
adenocarcinoma and malignant lymphoma (82.6% and 77.78%, respectively) afterward masses
(45.65% and 66.67%, respectively). However; masses represented the main thoracoscopic ﬁnding
(100%) in malignant mesothelioma followed by nodules (50%).
Conclusion: Inspecting pleural cavity via medical thoracoscopy and identiﬁcation of macro-
scopic appearance of different malignant pleural lesions may give a good prospect about the sus-
pected pathological type of malignancy in malignant pleural effusion.
ª 2014 The Egyptian Society of Chest Diseases and Tuberculosis. Production and hosting by Elsevier
B.V. All rights reserved.Introduction
Malignant pleural effusion (MPE) is one of the most common
problems faced by clinicians in their everyday practice [1].
MPE usually presents in the disseminated and advanced stage
of malignancy [2]. In one postmortem series, malignant
effusions were found in 15% of patients who died withd.
400 A.M. Abumossalam et al.malignancies. Although there have been no epidemiologic
studies, malignant pleural effusion is also one of the leading
causes of exudative effusion; studies have demonstrated that
42–77% of exudative effusions are secondary to malignancy
[1]. Nearly all neoplasms have been reported to involve the
pleura. In most studies, however, lung carcinoma has been
the most common neoplasm, accounting for approximately
one third of all malignant effusions. Breast carcinoma is the
second most common. Lymphomas, including both Hodgkin’s
disease and non-Hodgkin’s lymphoma, are also an important
cause of malignant pleural effusions. In 5–10% of malignant
effusions, no primary tumor is identiﬁed [3]. The incidence of
mesothelioma varies according to the geographic location.
Postmortem studies suggest that most pleural metastases arise
from tumor emboli to the visceral pleural surface, with second-
ary seeding to the parietal pleura. Other possible mechanisms
include direct tumor invasion (in lung cancers, chest wall neo-
plasm and breast carcinoma), haematogenous spread to parie-
tal pleura and lymphatic involvement. Interference with the
integrity of the lymphatic system anywhere between the parie-
tal pleura and mediastinal lymph nodes can result in pleural
ﬂuid formation [4]. Thoracoscopy is highly sensitive for detect-
ing pleural neoplasia with negative pleural ﬂuid cytology [5].
The possibility of visualizing the pleural cavity and obtaining
directed biopsy specimens accounts for diagnosis of more than
90% of pleural neoplasia [6–8]. However, its precise indication
in the workup of patients with pleural effusion remains contro-
versial [9]. So; the aim of this study is to identify the relation-
ship between thoracoscopic view of different malignant pleural
lesions and pathological types of malignancy in malignant
pleural effusion.Table 1 Type of malignancy according to ﬁnal diagnosis of
the studied cases.
Type of malignancy Frequency Valid percent
Metastatic adenocarcinoma 46 66.7
Malignant lymphoma 9 13.0
Malignant mesothelioma 4 5.8
Metastatic squamous cell carcinoma 4 5.8
Small cell carcinoma 3 4.3
Sarcoma 2 2.9
Spindle cell tumor 1 1.4
Total 69 100.0Subjects and methods
Patients
A retrospective study reviewed medical thoracoscopic reports
of 69 patients with pleural effusion underwent medical thora-
coscopy and conﬁrmed to be malignant in the chest depart-
ment of Mansoura University hospital between January 2013
and April 2014.
Methods
Prethoracoscopy assessment
For each patient, the following were reviewed: (1) detailed
medical history, (2) investigations done to reach the ﬁnal diag-
nosis including; chest radiographs and chest-CTs, pleural aspi-
ration with cytology and closed pleural biopsy.
Thoracoscopy procedure
Prior to the thoracoscopy procedure, pleural effusion was
drained and ipsilateral pneumothorax was induced, both in
the endoscopy suite. Thoracoscopy was usually done under
local anesthesia with spontaneous breathing and mild sedation
(midazolam, fentanyl) by an experienced pulmonologist in the
operating room. Patients were placed in lateral decubitus posi-
tion, with the involved side upward. After skin sterilization, a
small skin incision was done with blunt dissection to enter thepleural space between the third and sixth intercostal space,
along the midaxillary line. The ribs were not spread. A rigid
thoracoscope (Karl Storz, Germany) was inserted, and the
pleural cavity was visualized. The parietal, visceral and dia-
phragmatic pleurae were successively inspected and any path-
ological lesions were described and identiﬁed as well as the
mediastinal vessels and lymph nodes were inspected also. Biop-
sies were performed under direct visual control in all suspect
areas, systematically in several parts of the parietal pleura,
and sometimes in the visceral pleura, with diathermy forceps.
All thoracoscopic pleural biopsies were stained by hematoxylin
and eosin and examined by an expert pathologist to diagnose
the histopathological type of malignancy. An intercostal tube
was inserted before wound closure to evacuate air and ﬂuid.
Chest radiographs were routinely obtained with a portable
unit, immediately after the procedure and daily thereafter until
chest tube removal. On malignant diagnosis cases underwent
pleurodesis routinely. Once the lung had expanded and drain
output had decreased to less than 50 ml per 24 h, chest tube
was removed.
Postthoracoscopy assessment
The recorded major and minor complications were considered.
Major complications were retrospectively deﬁned as events
requiring active medical management during the hospital stay.
Minor complications were events requiring medical supervi-
sion only. The duration of drainage was measured from the
day medical thoracoscopy was performed to the day on which
the chest tube was removed.
Statistical analysis
Data were analyzed using SPSS (Statistical Package for Social
Sciences) version 21. Qualitative data were presented as num-
ber and percentage. Quantitative data were presented for nor-
mality by Kolmogorov–Smirnov test. Normally distributed
data were presented as mean and standard deviation. Compar-
ison between ﬁnal diagnosis was done using Chi-square test. P
value <0.05 was considered signiﬁcant.
Results
The mean age of studied population was 53.59 years with stan-
dard deviation 11.9 with age range from 20 to 78 years. Forty-
one were males (59.45%) and twenty-eight of them were
females (40.6%).
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with malignant pleural effusion were categorized into meta-
static adenocarcinoma (46 cases 66.7%), malignant lymphoma
(9 cases 13%) malignant mesothelioma and metastatic squa-
mous cell carcinoma (4 cases 5.8% for each) small cell carci-
noma (3 cases 4.3%), sarcoma (2 cases 2.9%) and spindle
cell tumor (one case 1.4%).
As revealed in Table 2 malignant pleural effusion showed
higher percentage in thoracoscopic nodules (75.45%) followed
by masses (50.7%), plaques (20.3%) and last of all adhesions
(14.5%). Metastatic adenocarcinoma proved to be in higher
percentage in thoracoscopic nodules (82.6%) followed by mass
(45.65%) while adhesions and plaques were present in 10.86%
for each. Malignant lymphoma presented higher percentage in
thoracoscopic nodules also (77.78%) followed by masses
(66.67%) then thoracoscopic plaques and adhesions 44.45%
for each. Malignant mesothelioma demonstrated higher per-
centage in thoracoscopic mass (100%) followed by thoraco-
scopic nodules (50%). Thoracoscopic mass and plaques were
present in all cases with sarcoma while adhesions represented
in half of the cases. 2/3 of small cell carcinoma presented pla-
ques however only 1/3 of cases presented nodules. Spindle cell
tumor represented only in one case that revealed just thoraco-
scopic mass. All cases of metastatic squamous cell carcinoma
had nodules unlike masses and plaques that were present in
25% of cases. To be noted more than one ﬁnding may be
present in the patient. Signiﬁcant statistical differences were
present as regards all thoracoscopic ﬁndings apart from tho-
racoscopic adhesions.
In this study as shown in Table 3, the presence of more than
one thoracoscopic ﬁnding may refer to certain diagnosis or aid
in conﬁrming the malignancy consequently presence of two
thoracoscopic ﬁndings accounted for 77.8% of cases with
malignant lymphoma while malignant mesothelioma presented
equal percentage for one or two ﬁndings (50% for each). Met-
astatic adenocarcinoma showed higher percentage of one ﬁnd-
ing (54.3%) followed by two ﬁndings (41.3%) lastly threeTable 2 Relation between thoracoscopic ﬁndings and type of malig
Type of malignancy
Metastatic adenocarcinoma (n= 46) No.
%
Malignant lymphoma (n= 9) No.
%
Malignant mesothelioma (n= 4) No.
%
Metastatic squamous cell carcinoma (n= 4) No.
%
Small cell carcinoma (n= 3) No.
%
Sarcoma (n= 2) No.
%
Spindle cell tumor (n= 1) No.
%
Total (n= 69) No.
%
P valueﬁndings (4.3%), sarcoma and metastatic squamous cell carci-
noma demonstrated equal percentage for two types, the former
showed two and three ﬁndings and the latter showed one and
two thoracoscopic ﬁndings. Spindle cell tumor and small cell
carcinoma proved that one ﬁnding was present in each tho-
racoscopic examination.
In this study, medical thoracoscopy revealed that all cases
with pleural plaques were detected on the parietal pleura how-
ever the rest of cases with pleural nodules, masses were present
on in both visceral and parietal layers and cases with isolated
lesions on either layer could not be delineated. In addition we
could not demarcate speciﬁc lesions for pleural partitions as
costal, diaphragmatic or mediastinal parts due to the degree
of extension. Adhesions also were involving both pleural layers.
Complications reported in this study were few and of low
risk. Five patients (7.25%) had thoracoscopic-related compli-
cations during this study. Two of them had empyema
(2.89%); one had a residual pneumothorax (1.45%), one
had subcutaneous emphysema (1.45%) and one had tumor
implantation at the site of medical thoracoscopy tract
(1.45%). These complications were properly managed. No
bleeding or mortality was reported in our study and mortality
rate was 0%.Discussion
Over the time, medical thoracoscopy (MT) is still conﬁrming
that the dilemma of pleural effusion could not be actually
worked out without its help. In this study sixty-nine patients
underwent MT and showed malignant etiology of pleura effu-
sion. Various types of macroscopic features (mass, nodules,
plaques and adhesions) in pleural layers; visceral and parietal;
can be visualized including costal, mediastinal and diaphrag-
matic partitions. For these, MT can be valuable in magniﬁca-
tion of panoramic view of the hemithorax with high resolution
for details as well as allows adequate biopsy specimens accessnancy in the studied cases.
Mass Nodule Plaques Adhesion
21 38 5 5
45.65% 82.6% 10.86% 10.86%
6 7 4 4
66.67% 77.78% 44.45% 44.45%
4 2 0 0
100% 50% 0.0% 0.0%
1 4 1 0
25% 100% 25% 0.0%
0 1 2 0
0.0% 33.33% 66.67% 0.0%
2 0 2 1
100% 0.0% 100% 50%
1 0 0 0
100% 0.0% 0.0% 0.0%
35 52 14 10
50.7% 75.4% 20.3% 14.5%
0.05* 0.013* 0.004 0.086
Table 3 Relation between number of thoracoscopic ﬁndings and types of malignancy in the studied cases.
Type of malignancy Number of thoracoscopic ﬁndings Total
1 2 3 4
Metastatic adenocarcinoma (n= 46) No. 25 19 2 0 46
% 54.3% 41.3% 4.3% 0.0% 100.0%
Malignant lymphoma (n= 9) No. 0 7 1 1 9
% 0.0% 77.8% 11.1% 11.1% 100.0%
Malignant mesothelioma (n= 4) No. 2 2 0 0 4
% 50.0% 50.0% 0.0% 0.0% 100.0%
Metastatic squamous cell carcinoma (n= 4) No. 2 2 0 0 4
% 50.0% 50.0% 0.0% 0.0% 100.0%
Small cell carcinoma (n= 3) No. 3 0 0 0 3
% 100.0% 0.0% 0.0% 0.0% 100.0%
Sarcoma (n= 2) No. 0 1 1 0 2
% 0.0% 50.0% 50.0% 0.0% 100.0%
Spindle cell tumor (n= 1) No. 1 0 0 0 1
% 100.0% 0.0% 0.0% 0.0% 100.0%
Total (n= 69) No. 33 31 4 1 69
% 47.8% 44.9% 5.8% 1.4% 100.0%
402 A.M. Abumossalam et al.for histologic, and possibly immunocytologic examination [10],
and also gives the option for therapeutic procedures to be per-
formed like decortication, pleurectomy, mechanical pleurode-
sis, talc insufﬂation and last but not least, visual directed
placement of chest drains [11].
As revealed in Table 2 malignant pleural effusion showed
higher percentage in thoracoscopic nodules (75.45%) followed
by masses (50.7%), plaques (20.3%) and lastly adhesions in
14.5% of cases. This may be due to higher number of cases
of metastatic adenocarcinoma and malignant lymphoma
(Table 1) that are mainly presented by nodules (82.6% and
77.78%, respectively) (Table 2). This was in agreement with
study done by Jiang et al. (2013) [12] who found that; the endo-
scopic ﬁndings of malignant pleural effusion mostly showed
nodules of varying sizes. The nodules could be grape-like, cau-
liﬂower-like, fused into masses, or diffused small nodules and
the main pathological diagnosis of malignant pleural effusion
was pleural metastases (37.8% of cases). Metastatic adenocar-
cinoma proved to be in higher percentage in thoracoscopic
nodules (82.6%) this can be explained by implantation theory
of pleural metastasis and hematogenous dissemination fol-
lowed by mass (45.65%) while adhesions and plaques were
present in 10.86% for each. Malignant lymphoma presented
higher percentage in thoracoscopic nodules also (77.78%) fol-
lowed by masses (66.67%) then thoracoscopic plaques and
adhesions that showed 44.45% for each owing to dense lym-
phatic pleural enrichment and local form of spread. The classic
view of malignant pleural mesothelioma is a thickening in the
pleural space with encasement of the lung by rind like visceral
pleura. The tumor can form additional small nodules over the
diaphragmatic surfaces or other less involved areas. Hyalinized
pleural plaques over the parietal pleura and diaphragmatic sur-
face can become invaded by mesothelioma. Rare cases of
malignant mesothelioma are characterized by a single mass
lesion without the diffuse thickening or satellite nodules [13].
In this study malignant mesothelioma demonstrated higher
percentage in thoracoscopic mass (100%) followed bythoracoscopic nodules (50%); this due to small number of
cases as well as most of them were of mixed subtype.
Visually, according to England et al. (1991), sarcomatous
pleural tumors appeared round or ovoid in shape. They were
encapsulated and attached to the visceral, parietal, or, in 1
case, the intraparenchymal pleura by a pedicle. Two-thirds
of the tumors were attached to visceral pleura, often by a ped-
icle. The rest arose from the parietal pleura of the chest wall,
diaphragm, or mediastinum. Neoplasms in these atypical sites,
together with ﬁssural lesions and tumors ‘‘inverted’’ into
peripheral lung, were more often malignant [14]. In our study
thoracoscopic mass and plaques were present in all cases with
sarcoma due to ﬂeshy tumor type while adhesions represented
in half of the cases.
Two thirds of small cell carcinoma presented plaques how-
ever only one third presented nodules. Spindle cell tumor was
represented only in one case that revealed just thoracoscopic
mass. All cases of metastatic squamous cell carcinoma had
nodules, however, masses and plaques were present in 25%
of cases. Signiﬁcant statistical differences were present in all
thoracoscopic ﬁndings apart from adhesions.
A study done by Rodriquez-Panadero et al. (1989) [15] and
Light (2001) [16], demonstrated that involvement of the parie-
tal pleura is frequently patchy and that the parietal pleura is
involved later in the course of malignancy than the visceral
one.
In our study; medical thoracoscopy revealed that all the
cases of the pleural plaques were of parietal origin while the
rest of cases with nodules, masses were in both visceral and
parietal pleurae referring to the extensive degree of pleural
affection and advanced form of malignancy.
In this study presence of more than one thoracoscopic ﬁnd-
ing may refer to certain diagnosis or aid in conﬁrming the
malignancy. Two thoracoscopic ﬁndings account for 77.8%
of cases with malignant lymphoma while malignant mesotheli-
oma presented equal percentage for one and two ﬁndings (50%
for each). Metastatic adenocarcinoma viewed higher
Malignant pleural effusion 403proportion for one ﬁnding (54.3%) followed by two ﬁndings
(41.3%) lastly three ﬁndings (4.3%). Sarcoma and metastatic
squamous cell carcinoma demonstrated equal percentage for
each, the former for two and three thoracoscopic ﬁndings
and the later for one and two thoracoscopic ﬁndings. Spindle
cell tumor and small cell carcinoma proved that one ﬁnding
presented in their thoracoscopic examination. The presence
of more than one ﬁnding can increase the feasibility of biopsy
taking and hence diagnostic yields and accuracy especially in
tumors needing larger tissue sampling as lymphoma and malig-
nant mesothelioma as declared in study by Loddenkemper
(1998) [17] who stated that medical thoracoscopy should be
systematically performed, as it provides a better histological
classiﬁcation (larger biopsy specimens), and more precise stag-
ing, thus avoiding thoracotomy. In a series, malignancy was
strongly suspected in the initial evaluation of patients in whom
hidden neoplasm was later detected [18], [19]; and, alterna-
tively, when malignancy was not initially suspected, it was
detected in only 5% of the patients who were followed up
[20]. However, what does ‘‘high clinical suspicion of malig-
nancy’’ mean, and how can it be used in the workup of patients
with undiagnosed pleural effusion? Patients with malignant
pleural effusion present clinical differences compared with
those with benign effusions [21,22].
Medical thoracoscopy is a fairly safe procedure when per-
formed by a well-trained physician. Few minor complications
were reported in our study. Five patients (7.25%) had thoraco-
scopic-related complications during this study. Two patients
had empyema; one patient had a residual pneumothorax,
one patient had subcutaneous emphysema and one patient
had a tumor implantation at the site of the tract of medical
thoracoscopy. These complications were properly managed.
No bleeding or mortality was reported in our study and mor-
tality rate was 0%.
According to Shawgo (2000) [23], the main risks of thora-
coscopy are those associated with early complications after
the procedure as pulmonary edema and excessive bleeding
and or hemorrhage necessitating a thoracotomy to stop it.
According to a retrospective study by Blanc et al. (2002) [24]
of 168 cases, thoracoscopic complications detected were classi-
ﬁed into major complications that included death, severe sep-
sis, pulmonary embolism, hypercapnic coma these were of
equal incidence of percentage 0.6%, while empyema was
detected in (3.6%) of cases. On the other hand minor compli-
cations included residual pneumothorax (8.3%), subcutaneous
emphysema (5.3%), fever (3.6%) and opiates were prescribed
in 1.2% to control post procedure chest pain. In another study
Cho et al. (2002) [25] reported some cases of cardiac arrhyth-
mia–bradycardia <60 bpm in 13.6%, hypotension–ABP
<100 mmHg in 24.2% and hypoxemia–arterial SpO2 <90%
in 16.7% during thoracoscopic procedure.
Conclusion
Medical thoracoscopy plays an important role in the diagnosis
and management of malignant pleural effusions through direct
access, visualization, handling, biopsy and intervention.
Thoracoscopic appearance of malignant pleural lesions like
masses, nodules, plaques and adhesions may predict the
suspected pathological type of malignancy causing malignant
pleural effusion.Conﬂict of interests
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